20857-31-2

Basic information

• Product Name: 3-Pyridinecarboxylic acid, 6-forMyl-, ethyl ester
• Synonyms: 3-Pyridinecarboxylic acid, 6-forMyl-, ethyl ester;Ethyl 6-forMylnicotinate
• CAS NO: 20857-31-2
• Molecular Formula: C₉H₉NO₃
• Molecular Weight: 179.17266
• Mol File: 20857-31-2.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 287.1±25.0 °C(Predicted)
• Appearance: /
• Density: 1.204±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 1.79±0.10(Predicted)
• CAS DataBase Reference: 3-Pyridinecarboxylic acid, 6-forMyl-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarboxylic acid, 6-forMyl-, ethyl ester(20857-31-2)
• EPA Substance Registry System: 3-Pyridinecarboxylic acid, 6-forMyl-, ethyl ester(20857-31-2)

Safety Data

• Hazardous Substances Data: 20857-31-2(Hazardous Substances Data)

Usage

General Description

3-Pyridinecarboxylic acid, 6-formyl-, ethyl ester is a chemical compound with the molecular formula C9H9NO3. It belongs to the class of pyridinecarboxylic acids and esters and is commonly used in the pharmaceutical and agrochemical industries. It is known for its valuable properties, such as its use in the production of pharmaceutical drugs and as a precursor for the synthesis of various organic compounds. This chemical is also used in the production of flavor and fragrance ingredients. Its ethyl ester form makes it more suitable for various industrial applications, including as an intermediate in the production of other chemicals and as a component in the formulation of agrochemical products.

Upstream product

• 100-26-5 Pyridine-2,5-dicarboxylic acid 
• 5552-44-3 ethyl 2,5-pyridinedicarboxylate 
• 881-86-7 dimethyl 2,5-pyridine dicarboxylate 
• 35005-81-3 ethyl 6-(hydroxy-methyl)-pyrid-3-yl-carboxylate 

Relevant articles and documents

PHARMACEUTICAL COMPOUNDS

The invention provides a composition of matter which: ? (i) consists of at least 90 % by weight of an atropisomer (2A) and 0-10 % by weight of an atropisomer of formula (2B); or ? (ii) consists of at least 90 % by weight of an atropisomer (2B) and 0-10 %

NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF

There is provided a morpholine derivative represented by General Formula [1A] or a salt thereof. (In the formula, a ring A represents a ring represented by General Formula [I]; * represents a bonding position; Z2 represents CH or the like; Z1 represents CR6 or the like; R6 represents a hydrogen atom or the like; X1 represents CHR7 or the like; R7 represents a hydrogen atom or the like; X2 represents CH2 or the like; R1 and R2 are the same as or different from each other, and each of R1 and R2 represents a hydrogen atom or the like; R3, R4, and R5 are the same as or different from each other, and each of R3, R4, and R5 represents a hydrogen atom, NRaRb, or the like; and each of Ra and Rb represents a hydrogen atom, a C1-8 alkyl group which may have a substituent, or the like.)

Oxazoline antiproliferative agents

Compounds having Formula I are useful for treating cancer. Also disclosed are pharmaceutical compositions comprising compounds of Formula I, and methods of treating cancer in a mammal.